These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 23265089)

  • 21. Turn on, tune in, but don't drop out: The impact of neo-liberalism on magic mushroom users' (in)ability to imagine collectivist social worlds.
    Riley S; Thompson J; Griffin C
    Int J Drug Policy; 2010 Nov; 21(6):445-51. PubMed ID: 20810266
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Simultaneous polysubstance use among Danish 3,4-methylenedioxymethamphetamine and hallucinogen users: combination patterns and proposed biological bases.
    Licht CL; Christoffersen M; Okholm M; Damgaard L; Fink-Jensen A; Knudsen GM; Erritzoe D
    Hum Psychopharmacol; 2012 Jul; 27(4):352-63. PubMed ID: 22696164
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Hallucinogenic psilocybine containing mushrooms. Toxins contained in Danish wild mushrooms].
    Lassen JF; Ravn HB; Lassen SF
    Ugeskr Laeger; 1990 Jan; 152(5):314-7. PubMed ID: 2301080
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Psychedelic use and intimate partner violence: The role of emotion regulation.
    Thiessen MS; Walsh Z; Bird BM; Lafrance A
    J Psychopharmacol; 2018 Jul; 32(7):749-755. PubMed ID: 29807492
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The determination of psilocin and psilocybin in hallucinogenic mushrooms by HPLC utilizing a dual reagent acidic potassium permanganate and tris(2,2'-bipyridyl)ruthenium(II) chemiluminescence detection system.
    Anastos N; Lewis SW; Barnett NW; Sims DN
    J Forensic Sci; 2006 Jan; 51(1):45-51. PubMed ID: 16423222
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correlates of ecstasy use among students surveyed through the 1997 College Alcohol Study.
    Yacoubian GS
    J Drug Educ; 2003; 33(1):61-9. PubMed ID: 12773025
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New trends in drug use among youth in California.
    Siegel RK
    Bull Narc; 1985; 37(2-3):7-17. PubMed ID: 3878176
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dimethyltryptamine (DMT): prevalence, user characteristics and abuse liability in a large global sample.
    Winstock AR; Kaar S; Borschmann R
    J Psychopharmacol; 2014 Jan; 28(1):49-54. PubMed ID: 24284475
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Unpredictable Behavior Under the Influence of "Magic Mushrooms": A Case Report and Review of the Literature.
    Honyiglo E; Franchi A; Cartiser N; Bottinelli C; Advenier AS; Bévalot F; Fanton L
    J Forensic Sci; 2019 Jul; 64(4):1266-1270. PubMed ID: 30548541
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MDMA/ecstasy use and psilocybin use are associated with lowered odds of psychological distress and suicidal thoughts in a sample of US adults.
    Jones GM; Nock MK
    J Psychopharmacol; 2022 Jan; 36(1):46-56. PubMed ID: 34983249
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunochemical monitoring of psilocybin and psilocin to identify hallucinogenic mushrooms.
    Morita I; Oyama H; Kiguchi Y; Oguri A; Fujimoto N; Takeuchi A; Tanaka R; Ogata J; Kikura-Hanajiri R; Kobayashi N
    J Pharm Biomed Anal; 2020 Oct; 190():113485. PubMed ID: 32866746
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The pharmacology of psilocybin.
    Passie T; Seifert J; Schneider U; Emrich HM
    Addict Biol; 2002 Oct; 7(4):357-64. PubMed ID: 14578010
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Hallucinogenic mushrooms popular again--sale via Internet].
    Westberg U; Karlson-Stiber C
    Lakartidningen; 1999 Feb; 96(7):746-7. PubMed ID: 10087778
    [No Abstract]   [Full Text] [Related]  

  • 34. Psychosocial correlates of recreational ecstasy use among college students.
    Sim T; Jordan-Green L; Lee J; Wolfman J; Jahangiri A
    J Am Coll Health; 2005; 54(1):25-9. PubMed ID: 16050325
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Harm potential of magic mushroom use: a review.
    van Amsterdam J; Opperhuizen A; van den Brink W
    Regul Toxicol Pharmacol; 2011 Apr; 59(3):423-9. PubMed ID: 21256914
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Student's use of illicit drugs: a survey in a preventive health service].
    Morvan Y; Rouvier J; Olié JP; Lôo H; Krebs MO
    Encephale; 2009 Dec; 35 Suppl 6():S202-8. PubMed ID: 20141772
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Microscopic study of powders of hallucinogenic mushrooms--Psilocybe sp].
    Schäfer AT
    Arch Kriminol; 2000; 205(1-2):30-6. PubMed ID: 10726173
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lifetime use of MDMA/ecstasy and psilocybin is associated with reduced odds of major depressive episodes.
    Jones GM; Nock MK
    J Psychopharmacol; 2022 Jan; 36(1):57-65. PubMed ID: 34983261
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 5-Year trends in use of hallucinogens and other adjunct drugs among UK dance drug users.
    McCambridge J; Winstock A; Hunt N; Mitcheson L
    Eur Addict Res; 2007; 13(1):57-64. PubMed ID: 17172780
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Hallucinogenic fungi (psilocybe). Part II. Identification of Psilocybe semilanceata by PCR].
    Adamczyk A; Sadakierska-Chudy A; Janoszka J; Rymkiewicz A; Dobosz T
    Arch Med Sadowej Kryminol; 2007; 57(3):285-8. PubMed ID: 17907620
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.